EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Thyroid hormone receptor alpha modulates fibrogenesis in hepatic stellate cells

Paul Manka, Jason D Coombes, Svenja Sydor iD, Marzena K Swiderska-Syn, Jan Best, Karine Gauthier, Leo A van Grunsven, Ye H Oo, Cindy Wang, Anna M Diehl, Georg S Hönes iD, Lars C Moeller und 9 weitere

Liver International · 2024-01 · 44 (1) · 125-138

DOI: 10.1111/liv.15759 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Liver International, online erschienen am 23.10.2023. Verfasst von Paul Manka und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, University Hospital Knappschaftskrankenhaus, Ruhr-University Bochum, Bochum, Germany. Hauptthemen laut MEDLINE: Hepatic Stellate Cells, Fibroblasts. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Agencia Estatal de Investigación, Deutsche Forschungsgemeinschaft, European Association for the Study of the Liver.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Progressive hepatic fibrosis can be considered the final stage of chronic liver disease. Hepatic stellate cells (HSC) play a central role in liver fibrogenesis. Thyroid hormones (TH, e.g. thyroxine; T4 and triiodothyronine; T3) significantly affect development, growth, cell differentiation and metabolism through activation of TH receptor α and/or β (TRα/β). Here, we evaluated the influence of TH in hepatic fibrogenesis.

Design

Human liver tissue was obtained from explanted livers following transplantation. TRα‐deficient (TRα‐KO) and wild‐type (WT) mice were fed a control or a profibrogenic methionine‐choline deficient (MCD) diet. Liver tissue was assessed by qRT‐PCR for fibrogenic gene expression. In vitro, HSC were treated with TGFβ in the presence or absence of T3. HSC with stable TRα knockdown and TRα deficient mouse embryonic fibroblasts (MEF) were used to determine receptor‐specific function. Activation of HSC and MEF was assessed using the wound healing assay, Western blotting, and qRT‐PCR.

Results

TRα and TRβ expression is downregulated in the liver during hepatic fibrogenesis in humans and mice. TRα represents the dominant isoform in HSC. In vitro, T3 blunted TGFβ‐induced expression of fibrogenic genes in HSC and abrogated wound healing by modulating TGFβ signalling, which depended on TRα presence. In vivo, TRα‐KO enhanced MCD diet‐induced liver fibrogenesis.

Conclusion

These observations indicate that TH action in non‐parenchymal cells is highly relevant. The interaction of TRα with TH regulates the phenotype of HSC via the TGFβ signalling pathway. Thus, the TH–TR axis may be a valuable target for future therapy of liver fibrosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatic Stellate CellsFibroblastsAnimalsMiceHumansThyroid HormonesThyroid Hormone Receptors alphaTransforming Growth Factor beta

Stichwörter der Autor:innen

HSCTGFβliver fibrosisthyroid hormone receptor αthyroid hormones

Substanzen

Thyroid HormonesThyroid Hormone Receptors alphaTransforming Growth Factor beta

Autor:innen und Institutionen

  • Department of Internal Medicine, University Hospital Knappschaftskrankenhaus, Ruhr-University Bochum, Bochum, Germany.
  • Division of Gastroenterology and Hepatology, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.
  • Inflammation Biology, School of Immunology and Microbial Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.
  • Division of Gastroenterology and Hepatology, Department of Internal Medicine, Saint Louis University School of Medicine, St. Louis, Missouri, USA.
  • Institut de Génomique Fonctionnelle de Lyon, Univ Lyon, CNRS UMR 5242, INRAE USC 1370 École Normale Supérieure de Lyon, Université Claude Barnard Lyon, Lyon, France.
  • Department of Basic (Bio-)medical Sciences, Liver Cell Biology Research Group, Vrije Universiteit Brussel, Brussels, Belgium.

ORCID-Profile: Svenja Sydor, Georg S Hönes, Christian M Lange, Ali Canbay

Förderung

  • Agencia Estatal de Investigación
  • Deutsche Forschungsgemeinschaft
  • European Association for the Study of the Liver
  • Federación Española de Enfermedades Raras
  • Ministerio de Ciencia, Innovación y Universidades
  • Veterans Health Administration
  • Wilhelm-Laupitz-Foundation

Zitieren

APA

Manka, P., Coombes, J. D., Sydor, S., Swiderska-Syn, M. K., Best, J., Gauthier, K., van Grunsven, L. A., Oo, Y. H., Wang, C., Diehl, A. M., Hönes, G. S., Moeller, L. C., Figge, A., Boosman, R. J., Faber, K. N., Tannapfel, A., Goetze, O., Aspichueta, P., Lange, C. M., …, & Syn, W. K. (2024). Thyroid hormone receptor alpha modulates fibrogenesis in hepatic stellate cells. Liver International, 44(1), 125-138. https://doi.org/10.1111/liv.15759

Vancouver

Manka P, Coombes JD, Sydor S, Swiderska-Syn MK, Best J, Gauthier K, et al. Thyroid hormone receptor alpha modulates fibrogenesis in hepatic stellate cells. Liver International. 2024;44(1):125-138. doi:10.1111/liv.15759

BibTeX
@article{Manka2024,
  author = {Manka, Paul and Coombes, Jason D and Sydor, Svenja and Swiderska-Syn, Marzena K and Best, Jan and Gauthier, Karine and van Grunsven, Leo A and Oo, Ye H and Wang, Cindy and Diehl, Anna M and Hönes, Georg S and Moeller, Lars C and Figge, Anja and Boosman, René J and Faber, Klaas N and Tannapfel, Andrea and Goetze, Oliver and Aspichueta, Patricia and Lange, Christian M and Canbay, Ali and Syn, Wing-Kin},
  title = {Thyroid hormone receptor alpha modulates fibrogenesis in hepatic stellate cells},
  journal = {Liver International},
  year = {2024},
  volume = {44},
  number = {1},
  pages = {125--138},
  doi = {10.1111/liv.15759}
}
Kostenlos starten →